Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05862792 · ClinicalTrials.gov registry record
Liposomal Bupivacaine and Transoral Robotic Surgery
A clinical trial of Post Operative Pain and Oropharyngeal Cancer, sponsored by Geisinger Clinic.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT05862792 is a study of Post Operative Pain and Oropharyngeal Cancer that is actively recruiting participants, run by Geisinger Clinic. The registered enrollment target is 80 participants, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05862792, a study of Post Operative Pain and Oropharyngeal Cancer, is actively recruiting participants, sponsored by Geisinger Clinic.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is for patients with oropharyngeal squamous cell carcinoma. We want to learn more about how we can optimize pain control in patients who undergo transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. Our goal is to determine if a local anesthetic called EXPAREL® (Liposomal Bupivacaine) impacts postsurgical pain and swallow function in patients with oropharyngeal squamous cell carcinoma undergoing TORS. EXPAREL® is an FDA-approved anesthetic drug that provides long-lasting and precise pain relief when injected into the surgical wound. Our study team wants to determine if injecting EXPAREL® into the surgical wound will provide better pain relief and swallow function when compared to patients who do not undergo postoperative EXPAREL® injection. Both options for postoperative pain control are considered standard of care for patients undergoing TORS.
Conditions Studied
Interventions
- DRUG Liposomal bupivacaine
Study Locations (1)
Pennsylvania
- Geisinger Medical Center - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2026-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05862792
The ClinicalTrials.gov registry entry for NCT05862792 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 235-participant average among 56 other Post Operative Pain trials with a reported enrollment target (66% lower). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Post Operative Pain appearing as the primary indexed condition, and to 1 intervention - of which Liposomal bupivacaine is the first listed.
NCT05862792 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05862792 about?
NCT05862792 is a clinical study titled "Liposomal Bupivacaine and Transoral Robotic Surgery". This study is for patients with oropharyngeal squamous cell carcinoma. We want to learn more about how we can optimize pain control in patients who undergo transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. Our goal is to determine if a local anesthetic called EXPAREL® (Lipo...
What is the current status of trial NCT05862792?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2023-06-01. Estimated completion is 2026-01-15.
What conditions does trial NCT05862792 study?
This clinical trial studies the following conditions: Post Operative Pain, Oropharyngeal Cancer, Dysphagia, Oropharyngeal, Transoral Robotic Surgery.
What interventions are being tested in trial NCT05862792?
The interventions under investigation include: Liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT05862792?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05862792 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
-
Sensory Outcomes in Active Substance Users
RECRUITING
-
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
RECRUITING · NA
-
Preoperative Acetazolamide
RECRUITING · Phase 4
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
-
Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.